ConductScience.org, home

Paper23948300

Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.

Putoczki TL and 22 others. Cancer Cell, 2013. Cited by 353 papers, by iCite.

Cite this record

ConductScience Library. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Papers, record 23948300. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23948300

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.
PubMed
Journal
Cancer Cell
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
353
iCite
Relative citation ratio, by iCite
8.96
iCite
Revised in PubMed
2022-03-10
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Putoczki TLTracy L
2Thiem SStefan
3Loving AAndrea
4Busuttil RARita A
5Wilson NJNicholas J
6Ziegler PKPaul K
7Nguyen PMPaul M
8Preaudet AAdele
9Farid RRyan
10Edwards KMKirsten M
11Boglev YYeliz
12Luwor RBRodney B
13Jarnicki AAndrew
14Horst DDavid
15Boussioutas AAlex
16Heath JKJoan K
17Sieber OMOliver M
18Pleines IIrina
19Kile BTBenjamin T
20Nash AAndrew

Source PubMed

See all 23 authorsDownload CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell Transformation, NeoplasticMajor topic
Gastrointestinal NeoplasmsMajor topic
Interleukin-11Major topic
Interleukin-6Major topic
Animals
Gastric Mucosa
Humans
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Nude
Molecular Targeted Therapy
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in23948295IL-11: a prominent pro-tumorigenic member of the IL-6 family.https://conductscience.org/library/papers/23948295

Source PubMed

Download CSV of comments and corrections

Cited by232

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 353 citations.

PMIDTitleJournalYearIn PapersSource
42793141Interleukin-11 Signaling in Liver Disease: Mechanisms, Cellular Crosstalk, and Therapeutic Potential.Biomolecules2026https://conductscience.org/library/papers/42793141PubMed
42533123Inference of secreted protein signaling activities in intercellular communication.Nat Methods2026https://conductscience.org/library/papers/42533123PubMed
42514313Effect of an Ulva lactuca Extract on Systemic Antioxidant and Inflammatory Biomarkers in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.Nutrients2026https://conductscience.org/library/papers/42514313PubMed
42484928Beyond fibrosis: Emerging role of IL-11 in regulating innate and adaptive immune cell plasticity.Mol Biol Rep2026https://conductscience.org/library/papers/42484928PubMed
42466345Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42466345PubMed
42273671Bridging aging and colorectal cancer: synergistic roles of inflammaging and immunosenescence.Front Immunol2026https://conductscience.org/library/papers/42273671PubMed
42253941Gastric Cancer: Pathobiology and Therapeutics.MedComm (2020)2026https://conductscience.org/library/papers/42253941PubMed
41936612IL-11-IL6ST-STAT3 signaling defines a convergent inflammatory axis in esophageal cancer subtypes.Sci Rep2026https://conductscience.org/library/papers/41936612PubMed
41922722Pathophysiology of colitis-associated colorectal cancer.Nat Rev Gastroenterol Hepatol2026https://conductscience.org/library/papers/41922722PubMed
41558601Pan-cancer epigenetic landscape of human tumor-associated macrophages reveals crucial enhancers governing their heterogenous formation by Pol II pausing modulation.J Adv Res2026https://conductscience.org/library/papers/41558601PubMed
41487042NAD+-Dependent Enzyme SIRT3 Limits Intestinal Epithelial Cell Functions Through NAD+ Synthesis Pathway in Colorectal Cancer.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41487042PubMed
41438693Identification of PI3K/AKT/mTOR-related genes as diagnostic biomarkers for cutaneous squamous cell carcinoma.Biochem Biophys Rep2026https://conductscience.org/library/papers/41438693PubMed
41245384Fibroblast-derived interleukin-11 as a potential biomarker for intestinal fibrostenosis in Crohn's disease.Ther Adv Gastroenterol2025https://conductscience.org/library/papers/41245384PubMed
41178513Triple-Negative Breast Cancer Cells Resist Natural Killer Cell-Mediated Killing Through Interleukin-11 Trans-Signaling.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41178513PubMed
41159000The expression of metastasis associated protein 2 in normal development and cancers: mechanism and clinical significance.PeerJ2025https://conductscience.org/library/papers/41159000PubMed
41154660Oncotransformation in Bhas 42 Cell Transformation Assay by Typical Non-Genotoxic Carcinogens, PFOA and PFOS, and Time-Course Transcriptome Analysis.Biomolecules2025https://conductscience.org/library/papers/41154660PubMed
41153383Crossroads of Iron Metabolism and Inflammation in Colorectal Carcinogenesis: Molecular Mechanisms and Therapeutic Perspectives.Genes (Basel)2025https://conductscience.org/library/papers/41153383PubMed
40983666The immune microenvironment of colorectal cancer.Nat Rev Cancer2025https://conductscience.org/library/papers/40983666PubMed
40951163Novel Interleukin-11 Inhibitors Attenuate Collagen Production in Patient-Derived Synovial Fibroblasts.Cureus2025https://conductscience.org/library/papers/40951163PubMed
40673604Interleukin-11 promotes lung adenocarcinoma tumourigenesis and immune evasion.Clin Transl Med2025https://conductscience.org/library/papers/40673604PubMed

See all 232 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL113589PubTator's text mininghttps://conductscience.org/library/genes/3589NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
IL6ST3572PubTator's text mininghttps://conductscience.org/library/genes/3572NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GEOGSE43800

Source GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23948300

GET https://conductscience.org/api/papers/v1/23948300/authors?page=2